Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer

Major Program

Phase 0 I II Cancer Prevention Clinical Trials Program

Research Group

Gastrointestinal and Other Cancers

Status

Completed

NCT ID

NCT00983580

This phase II trial is studying how well giving acetylsalicylic acid together with eflornithine works in treating patients at high risk for colorectal cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acetylsalicylic acid and eflornithine may prevent colorectal cancer.

Intervention

Aspirin, Eflornithine, Laboratory Biomarker Analysis, Placebo, Telephone-Based Intervention

Condition

Adenomatous Polyp

Investigators

Frank A Sinicrope

See list of participating sites